NO COST-SHARING OF CERTAIN DRUGS

Summary

The bill stops group health plans and Medicaid from charging copays, deductibles or coinsurance on generic cholesterol‑lowering drugs, on second‑line step‑therapy drugs when generics fail, and on coronary artery calcium scans and cholesterol panels for people at intermediate heart‑disease risk. It applies to most insurance plans but excludes short‑term, catastrophic and high‑deductible plans until deductibles are met. The measure aims to improve access to preventive heart care and lower‑cost medication.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share